Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Journal of Clinical Immunology
Erschienen in: Journal of Clinical Immunology 1/2007

01.01.2007

Novel Analysis of Clonal Diversification in Blood B Cell and Bone Marrow Plasma Cell Clones in Immunoglobulin Light Chain Amyloidosis

verfasst von: ROSHINI S. ABRAHAM, MICHELLE K. MANSKE, NETA S. ZUCKERMAN, ABHISHEK SOHNI, HANNA EDELMAN, GITIT SHAHAF, MICHAEL M. TIMM, ANGELA DISPENZIERI, MORIE A. GERTZ, RAMIT MEHR

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Immunoglobulin light chain amyloidosis (AL) is characterized by a limited clonal expansion of plasma cells and amyloid formation. Here, we report restriction in the diversity of VL gene usage with a dominance of clonally related B cells in the peripheral blood (PB) isotype-specific repertoire of AL patients. A rigorous quantification of lineage trees reveals presence of intraclonal variations in the PB clones compared to the bone marrow (BM) clones, which suggests a common precursor that is still subject to somatic mutation. When compared to normal BM and PB B cells, AL clones showed significant but incomplete impairment of antigenic selection, which could not be detected by conventional R and S mutation analysis. Therefore, graphical analysis of B cell lineage trees and mathematical quantification of tree properties provide novel insights into the process of B cell clonal evolution in AL.
Literatur
1.
Gertz MA, Kyle RA: Primary systemic amyloidosis—A diagnostic primer. Mayo Clinic Proc 64:1505–1519, 1989
2.
Gertz MA, Lacy MQ, Dispenzieri A: Amyloidosis. Hematol Oncol Clin North Am 13:1211–1233, 1999PubMedCrossRef
3.
Kyle RA, Greipp PR: Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clinic Proc 58:665–683, 1983
4.
Kyle RA, Gertz MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Seminars Hematol 32:45–59, 1995
5.
Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818–1824, 1992PubMed
6.
Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE: Clonal circulating cells are common in plasma cell proliferative disorders: A comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 88:289–296, 1996PubMed
7.
Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ: Circulating plasma cells in multiple myeloma: Characterization and correlation with disease stage.[see comment]. Br J Haematol 97:46–55, 1997PubMedCrossRef
8.
Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108–113, 1993PubMedCrossRef
9.
Witzig TE: Detection of malignant cells in the peripheral blood of patients with multiple myeloma: Clinical implications and research applications. Mayo Clin Proc 69:903–907, 1994PubMed
10.
Witzig TE, Gertz MA, Pineda AA, Kyle RA, Greipp PR: Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol 89:640–642, 1995PubMed
11.
Witzig TE, Kimlinger TK, Ahmann GJ, Katzmann JA, Greipp PR: Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 26:113–120, 1996PubMedCrossRef
12.
Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR: Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: When is the optimal time for stem cell harvest? Leukemia Lymphoma 19:417–422, 1995PubMed
13.
Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ: Flow cytometric disease monitoring in multiple myeloma: The relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 100:3095–3100, 2002PubMedCrossRef
14.
Gertz MA, Witzig TE, Pineda AA, Greipp PR, Kyle RA, Litzow MR: Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplant 19:337–342, 1997PubMedCrossRef
15.
Comenzo RL, Michelle D, LeBlanc M, Wally J, Zhang Y, Kica G, Karandish S, Arkin CF, Wright DG, Skinner M, McMannis J: Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: Rationale and application. [see comment]. Transfusion 38:60–69, 1998PubMedCrossRef
16.
Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI: The growth fraction of human myeloma cells. Blood 57:333–338, 1981PubMed
17.
Hamburger A, Salmon SE: Primary bioassay of human myeloma stem cells. J Clin Invest 60:846–854, 1977PubMed
18.
Levy Y, Schmitt C, Tsapis A, Brouet JC, Fermand JP: Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol 84:435–439, 1991PubMed
19.
Guikema JE, Vellenga E, Veeneman JM, Hovenga S, Bakkus MH, Klip H, Bos NA: Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 104:748–754, 1999PubMedCrossRef
20.
Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023–1031, 1993PubMedCrossRef
21.
Pilarski LM, Masellis-Smith A, Szczepek A, Mant MJ, Belch AR: Circulating clonotypic B cells in the biology of multiple myeloma: Speculations on the origin of myeloma. Leukemia Lymphoma 22:375–383, 1996PubMed
22.
Mellstedt H, Hammarstrom S, Holm G: Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol 17:371–384, 1974PubMed
23.
Epstein J: Myeloma stem cell phenotype. Implications for treatment. Hematol-Oncol Clin North Am 11:43–49, 1997PubMedCrossRef
24.
Berenson JR, Vescio RA, Said J: Multiple myeloma: The cells of origin—a two-way street. Leukemia 12:121–127, 1998PubMedCrossRef
25.
Mitterer M, Oduncu F, Lanthaler AJ, Drexler E, Amaddii G, Fabris P, Emmerich B, Coser P, Straka C: The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients.[see comment]. Br J Haematol 106:737–743, 1999PubMedCrossRef
26.
Davies FE, Rawstron AC, Owen RG, Morgan GJ: Controversies surrounding the clonogenic origin of multiple myeloma.[comment]. Br J Haematol 110:240–241, 2000PubMedCrossRef
27.
Rawstron AC, Barrans SL, Blythe D, English A, Richards SJ, Fenton JA, Davies FE, Child JA, Jack AS, Morgan GJ: In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.[see comment]. Br J Haematol 113:794–802, 2001PubMedCrossRef
28.
Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM: In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.[erratum appears in Blood 1995 Jun 1; 85(11):3365]. Blood 85:436–447, 1995PubMed
29.
Rasmussen T, Kastrup J, Knudsen LM, Johnsen HE: High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma. Br J Haematol 105:265–267, 1999PubMed
30.
Mitterer M, Lanthaler AJ, Schnabel B, Svaldi M, Oduncu F, Coser P, Emmerich B, Huemer H, Straka C: Peripheral blood monoclonal B-cells predict the event free survival in multiple myeloma. Leukemia Lymphoma 41:387–395, 2001PubMed
31.
Perfetti V, Ubbiali P, Magni M, Colli Vignarelli M, Casarini S, Matteucci P, Gianni AM, Merlini G: Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis. Bone Marrow Transplant 23:323–327, 1999PubMedCrossRef
32.
Perfetti V, Vignarelli MC, Bellotti V, Glennie MJ, Zorzoli I, Ubbiali P, Obici L, Massa M, Ippoliti G, Ascari E, Merlini G: Membrane CD22 defines circulating myeloma-related cells as mature or later B cells. Lab Invest 77:333–344, 1997PubMed
33.
Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ: Characterization of clonogenic multiple myeloma cells. Blood 103:2332–2336, 2004PubMedCrossRef
34.
Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR: The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283–3290, 1994PubMed
35.
Szczepek AJ, Bergsagel PL, Axelsson L, Brown CB, Belch AR, Pilarski LM: CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood 89:1824–1833, 1997PubMed
36.
Abraham RS, Geyer SM, Price-Troska TL, Allmer C, Kyle RA, Gertz MA, Fonseca R: Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood 101:3801–3808, 2003PubMedCrossRef
37.
Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder Jr HW, Ferrarini M, Chiorazzi N: Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515–1525, 1998PubMedCrossRef
38.
Dunn-Walters D, Belelovsky A, Edelman H, Banerjee M, Mehr R: The dynamics of germinal centre selection as measured by graph-theoretical analysis of mutational lineage trees. Develop Immunol 9:233–245, 2003CrossRef
39.
Dunn-Walters D, Edelman H, Mehr R: Immune system learning and memory quantified by graphical analysis of B-lymphocyte phylogenetic trees. Bio Sys 76:141–155, 2004
40.
Mehr R, Edelman H, Sehgal D, Mage R: Analysis of mutational lineage trees from sites of primary and secondary Ig gene diversification in rabbits and chickens. J Immunol 172:4790–4796, 2004PubMed
41.
Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc 57:289–300, 1995
42.
Lossos IS, Tibshirani R, Narasimhan B, Levy R: The inference of antigen selection on Ig genes. J Immunol 165:5122–5126, 2000PubMed
43.
Kocks C, Rajewsky K: Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc Nat Acad Sci US Am 85:8206–8210, 1988CrossRef
44.
Manser T: Evolution of antibody structure during the immune response. The differentiative potential of a single B lymphocyte. J Exp Med 170:1211–1230, 1989PubMedCrossRef
45.
Jacob J, Kelsoe G, Rajewsky K, Weiss U: Intraclonal generation of antibody mutants in germinal centres. [see comment]. Nature 354:389–392, 1991PubMedCrossRef
46.
Jacob J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 176:679–687, 1992PubMedCrossRef
47.
Shannon M, Mehr R: Reconciling repertoire shift with affinity maturation: The role of deleterious mutations. J Immunol 162:3950–3956, 1999PubMed
48.
Jacob J, Przylepa J, Miller C, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med 178:1293–1307, 1993PubMedCrossRef
49.
Banerjee M, Mehr R, Belelovsky A, Spencer J, Dunn-Walters D: Age and tissue-specific differences in human germinal centre B cell selection. Euro J Immunol 32:1947–1957, 2002CrossRef
50.
Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG: The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805–811, 1987PubMedCrossRef
51.
Kepler TB: Codon bias and plasticity in immunoglobulins. Mole Biol Evol 14:637–643, 1997
52.
Dunn-Walters DK, Spencer J: Strong intrinsic biases towards mutation and conservation of bases in human IgVH genes during somatic hypermutation prevent statistical analysis of antigen selection. Immunology 95:339–345, 1998PubMedCrossRef
53.
Berek C: The development of B cells and the B-cell repertoire in the microenvironment of the germinal center. Immunol Rev 126:5–19, 1992PubMedCrossRef
54.
Levy R, Levy S, Cleary ML, Carroll W, Kon S, Bird J, Sklar J: Somatic mutation in human B-cell tumors. Immunol Rev 96:43–58, 1987PubMedCrossRef
55.
Jacobs H, Bross L: Towards an understanding of somatic hypermutation. Curr Opin Immunol 13:208–218, 2001PubMedCrossRef
56.
Perfetti V, Ubbiali P, Vignarelli MC, Diegoli M, Fasani R, Stoppini M, Lisa A, Mangione P, Obici L, Arbustini E, Merlini G: Evidence that amyloidogenic light chains undergo antigen-driven selection. Blood 91:2948–2954, 1998PubMed
57.
Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80:2326–2335, 1992PubMed
58.
Vescio RA, Cao J, Hong CH, Lee JC, Wu CH, Der Danielian M, Wu V, Newman R, Lichtenstein AK, Berenson JR: Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 155:2487–2497, 1995PubMed
59.
Taylor BJ, Pittman JA, Seeberger K, Mant MJ, Reiman T, Belch AR, Pilarski LM: Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: Insights into the evolution of the myeloma clone. Clin Can Res 8:502–513, 2002
60.
Kosmas C, Stamatopoulos K, Stavroyianni N, Belessi C, Viniou N, Yataganas X: Molecular analysis of immunoglobulin genes in multiple myeloma. Leukemia Lymphoma 33:253–265, 1999PubMed
61.
Kuppers R, Klein U, Hansmann ML, Rajewsky K: Cellular origin of human B-cell lymphomas. New England J Med 341:1520–1529, 1999CrossRef
62.
Bahler DW, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Nat Acad Sci US Am 89:6770–6774, 1992CrossRef
63.
Matolcsy A, Schattner EJ, Knowles DM, Casali P: Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Euro J Immunol 29:1253–1264, 1999CrossRef
64.
Jain R, Roncella S, Hashimoto S, Carbone A, Francia di Celle P, Foa R, Ferrarini M, Chiorazzi N: A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol 153:45–52, 1994PubMed
65.
Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021–3029, 1991PubMed
66.
Sahota SS, Garand R, Mahroof R, Smith A, Juge-Morineau N, Stevenson FK, Bataille R: V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Blood 94:1070–1076, 1999PubMed
67.
Sahota SS, Leo R, Hamblin TJ, Stevenson FK: Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.[see comment]. Blood 89:219–226, 1997PubMed
68.
Sahota SS, Leo R, Hamblin TJ, Stevenson FK: Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 87:746–755, 1996PubMed
69.
Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM: A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood 92:2844–2855, 1998PubMed
70.
Zaitoun AM: Cell population kinetics of the germinal centres of lymph nodes of BALB/c mice. J Anato 130:131–137, 1980
71.
MacLennan IC, Johnson GD, Liu YJ, Gordon J: The heterogeneity of follicular reactions. Res Immunol 142:253–257, 1991PubMedCrossRef
72.
Razzeca KJ, Pillemer E, Weissman IL, Rouse RV: In situ identification of idiotype-positive cells participating in the immune response to phosphorylcholine. Euro J Immunol 16:393–399, 1986
73.
Abraham RS, Geyer SM, Ramirez-Alvarado M, Price-Troska TL, Gertz MA, Fonseca R: Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL). J Clin Immunol 24:340–353, 2004PubMedCrossRef
74.
Comenzo RL, Zhang Y, Martinez C, Osman K, Herrera GA: The tropism of organ involvement in primary systemic amyloidosis: Contributions of Ig V(L) germ line gene use and clonal plasma cell burden. Blood 98:714–720, 2001PubMedCrossRef
Metadaten
Titel
Novel Analysis of Clonal Diversification in Blood B Cell and Bone Marrow Plasma Cell Clones in Immunoglobulin Light Chain Amyloidosis
verfasst von
ROSHINI S. ABRAHAM
MICHELLE K. MANSKE
NETA S. ZUCKERMAN
ABHISHEK SOHNI
HANNA EDELMAN
GITIT SHAHAF
MICHAEL M. TIMM
ANGELA DISPENZIERI
MORIE A. GERTZ
RAMIT MEHR
Publikationsdatum
01.01.2007
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2007
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9056-9

Weitere Artikel der Ausgabe 1/2007

Journal of Clinical Immunology 1/2007 Zur Ausgabe

OriginalArticle

Primary Immunodeficiency Diseases in Latin America: The Second Report of the LAGID Registry

OriginalArticle

CTLA-4 Gene Exon-1 +49 A/G Polymorphism: Lack of Association with Autoimmune Disease in Patients with Common Variable Immune Deficiency

OriginalPaper

The Expression of Retinoic Acid Receptors in Lymph Nodes of Young Children and the Effect of All-trans-Retinoic Acid on the B Cells from Lymph Nodes

OriginalPaper

“Spicing Up” of the Immune System by Curcumin

Original Paper

Similar CD19 Dysregulation in Two Autoantibody-Associated Autoimmune Diseases Suggests a Shared Mechanism of B-Cell Tolerance Loss

Original Paper

The Effect of Natural Killer Cell Killer Ig-Like Receptor Alloreactivity on the Outcome of Bone Marrow Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

17.04.2024 | DGIM 2024 | Nachrichten

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise